Today, the US Senate confirmed President Biden’s nominee for National Institutes of Health (NIH) Director, Monica Bertagnolli, MD, who will lead the country’s top medical research institute. “We are thrilled that the US Senate has confirmed Dr. Monica Bertagnolli as the new Director of the NIH, as she is an esteemed leader with an impressive career that will guide the Institute forward.”
“We congratulate Dr. Bertagnolli on the confirmation and are excited to see her leadership as the head of NIH. At Global Alzheimer’s Platform Foundation (GAP), we know that the right leaders in place will advance the desperately needed clinical research for Alzheimer’s disease to help find a cure. We are eager to see what lies ahead under Dr. Bertagnolli’s leadership and are encouraged by her commitment to health equity, as we know that prioritizing diversity and inclusion is the only way forward when it comes to clinical research.”
For immediate release:
About Global Alzheimer’s Platform Foundation (GAP)
The nonprofit Global Alzheimer’s Platform Foundation® was founded to speed the delivery of Alzheimer’s treatments with a commitment to promoting diversity in clinical research, as well as lowering the cost and duration of clinical trials to ensure that no one is left behind. As part of its mission, GAP supports more than 100 clinical research sites around the world through study start up and recruitment activities, promoting diversity in research studies, and recognizing the citizen scientists who make research possible.